News Neuron23™ Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group Biotechnology company launches to accelerate development of precision medicines for genetically defined neurological and immunological diseases SOUTH SAN FRANCISCO, Calif., December 16, 2020 – Neuron23™…fefifoliosDecember 15, 2020
